日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 1 dose-escalation study of IBI324, a VEGF-A/Ang-2 bispecific antibody, for the treatment of diabetic macular oedema

IBI324(一种VEGF-A/Ang-2双特异性抗体)治疗糖尿病性黄斑水肿的I期剂量递增研究

Wang, Zilin; Sun, Junran; Liu, Kun; Tao, Liming; Liu, Qinghuai; Wu, Miaoqin; Lu, Shujie; Deng, Junjie; Li, Li; Qian, Lei; Li, Xiaorong; Sun, Xiaodong

Ang-2 modulates VEGFR3-induced lymphangiogenesis in peritumoral adipose tissue of metastatic head and neck cancer

Ang-2 调节转移性头颈癌肿瘤周围脂肪组织中 VEGFR3 诱导的淋巴管生成

Yang, Li-Yun; Zhang, Jian-Wei; Hu, An

Comprehensive biomarker and modeling approach to support dose finding for BI 836880, a VEGF/Ang-2 inhibitor

综合生物标志物和建模方法支持 VEGF/Ang-2 抑制剂 BI 836880 的剂量探索

Sascha Keller, Ulrich Kunz, Ulrike Schmid, Jack Beusmans, Martin Büchert, Min He, Girish Jayadeva, Christophe Le Tourneau, Doreen Luedtke, Heiko G Niessen, Zohra Oum'hamed, Sina Pleiner, Xiaoning Wang, Ralph Graeser

Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous

Ang-1、Ang-2 和 Tie2 是亨诺赫-舍恩莱因紫癜和儿童期发病的系统性红斑狼疮的诊断生物标志物。

Jia, Lishan; Li, Xiaozhong; Shen, Jiayun; Teng, Yan; Zhang, Baoqin; Zhang, Min; Gu, Yueqin; Xu, Hong

Understanding yellow fever-associated myocardial injury: an autopsy study

了解黄热病相关心肌损伤:尸检研究

Fernando Rabioglio Giugni, Vera Demarchi Aiello, Caroline Silverio Faria, Shahab Zaki Pour, Marielton Dos Passos Cunha, Melina Valdo Giugni, Henrique Trombini Pinesi, Felipe Lourenço Ledesma, Carolina Esteves Morais, Yeh-Li Ho, Jaques Sztajnbok, Sandra de Morais Fernezlian, Luiz Fernando Ferraz da S

ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia

ANG2阻断可减轻遗传性出血性毛细血管扩张症模型中相关的促血管生成性脑血管缺陷

Xingyan Zhou ,Jenna C Pucel ,Aya Nomura-Kitabayashi ,Pallavi Chandakkar ,Adella P Guidroz ,Nikita L Jhangiani ,Duran Bao ,Jia Fan ,Helen M Arthur ,Christoph Ullmer ,Christian Klein ,Philippe Marambaud ,Stryder M Meadows

Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling

补肺益肾Ⅲ号有效复方联合ER抑制COPD大鼠气道黏液高分泌:通过EGFR/MAPK信号传导

Kexin Xu #, Jindi Ma #, Ruilong Lu, Xuejie Shao, Yakun Zhao, Lili Cui, Zhiguang Qiu, Yange Tian, Jiansheng Li

Paricalcitol Improves the Angiopoietin/Tie-2 and VEGF/VEGFR2 Signaling Pathways in Adriamycin-Induced Nephropathy

帕立骨化醇改善阿霉素肾病中的血管生成素/Tie-2 和 VEGF/VEGFR2 信号通路

Amanda Lima Deluque, Beatriz Magalhães Oliveira, Cláudia Silva Souza, Ana Lívia Dias Maciel, Heloísa Della Coletta Francescato, Cleonice Giovanini, Lucas Ferreira de Almeida, Francisco José Albuquerque de Paula, Roberto Silva Costa, José Antunes-Rodrigues, Terezila Machado Coimbra

Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome

血管生成素 2 与 2019 冠状病毒病急性呼吸窘迫综合征中的血管坏死性凋亡诱导有关

David R Price, Elisa Benedetti, Katherine L Hoffman, Luis Gomez-Escobar, Sergio Alvarez-Mulett, Allyson Capili, Hina Sarwath, Christopher N Parkhurst, Elyse Lafond, Karissa Weidman, Arjun Ravishankar, Jin Gyu Cheong, Richa Batra, Mustafa Büyüközkan, Kelsey Chetnik, Imaani Easthausen, Edward J Schenc

Baseline Ang-2 Serum Levels as a Predictive Factor for Survival in NSCLC and SCLC.

基线 Ang-2 血清水平作为 NSCLC 和 SCLC 生存的预测因素

Nikolakopoulou Asimina, Tsakogiannis Dimitris, Zagouri Flora, Zografos Eleni, Tzioga Lamprini, Stratakos Grigorios, Koulouris Nikolaos, Syrigos Konstantinos, Bletsa Garyfalia